Tumor-educated circulating monocytes are powerful specific biomarkers for diagnosis of colorectal cancer-GSE47756
Analysis of tumor-educated changes in peripheral blood monocytes at the gene expression level.
--
Peripheral blood monocytes from 93 distinct individuals are profiled on 8 beadchips. The individuals belong to one of three groups: healthy volunteers (38), patients with non-metastatic colorectal cancer (27) or patients with metastatic colorectal cancer (28).
--
--
--
Sample ID | Age | Gender | !Sample_title | tumor stage |
---|---|---|---|---|
GSM1156513 | 73 | F | PBM_PM_Nb49 | metastatic patient |
GSM1156514 | 57 | F | PBM_P_Nb51 | non-metastatic patient |
GSM1156515 | 58 | F | PBM_P_Nb52 | non-metastatic patient |
GSM1156516 | 45 | F | PBM_PM_Nb53 | metastatic patient |
GSM1156517 | 73 | M | PBM_PM_Nb54 | metastatic patient |
File |
---|
All fields are editable except the "Sample ID" column. To edit a cell, click within the cell. To edit a "date" cell, click on the calendar icon. To cancel an edit, press the ESC key.
Sample ID | Age | Gender | !Sample Title | Tumor stage |
---|---|---|---|---|
GSM1156513 | 73 |
F |
PBM_PM_Nb49 |
metastatic patient |
GSM1156514 | 57 |
F |
PBM_P_Nb51 |
non-metastatic patient |
GSM1156515 | 58 |
F |
PBM_P_Nb52 |
non-metastatic patient |
GSM1156516 | 45 |
F |
PBM_PM_Nb53 |
metastatic patient |
GSM1156517 | 73 |
M |
PBM_PM_Nb54 |
metastatic patient |
GSM1156518 | 58 |
F |
PBM_PM_Nb55 |
metastatic patient |
GSM1156519 | 70 |
M |
PBM_P_Nb56 |
non-metastatic patient |
GSM1156520 | 77 |
F |
PBM_P_Nb57 |
non-metastatic patient |
GSM1156521 | 44 |
M |
PBM_PM_Nb58 |
metastatic patient |
GSM1156522 | 75 |
F |
PBM_P_Nb59 |
non-metastatic patient |
GSM1156523 | 51 |
F |
PBM_PM_Nb60 |
metastatic patient |
GSM1156524 | 54 |
M |
PBM_PM_Nb61 |
metastatic patient |
GSM1156525 | 87 |
M |
PBM_P_Nb2 |
non-metastatic patient |
GSM1156526 | 59 |
M |
PBM_PM_Nb7 |
metastatic patient |
GSM1156527 | 60 |
M |
PBM_PM_Nb10 |
metastatic patient |
GSM1156528 | 67 |
M |
PBM_P_Nb26 |
non-metastatic patient |
GSM1156529 | 49 |
M |
PBM_P_Nb34 |
non-metastatic patient |
GSM1156530 | 52 |
F |
PBM_PM_Nb36 |
metastatic patient |
GSM1156531 | 54 |
F |
PBM_P_Nb38 |
non-metastatic patient |
GSM1156532 | 45 |
F |
PBM_P_Nb41 |
non-metastatic patient |
GSM1156533 | 45 |
F |
PBM_P_Nb42 |
non-metastatic patient |
GSM1156534 | 53 |
M |
PBM_PM_Nb45 |
metastatic patient |
GSM1156535 | 58 |
M |
PBM_PM_Nb46 |
metastatic patient |
GSM1156536 | 75 |
F |
PBM_P_Nb47 |
non-metastatic patient |
GSM1156537 | 65 |
M |
PBM_HV_Nb27 |
healthy volunteer |
GSM1156538 | 41 |
F |
PBM_HV_Nb28 |
healthy volunteer |
GSM1156539 | 42 |
M |
PBM_HV_Nb29 |
healthy volunteer |
GSM1156540 | 63 |
M |
PBM_HV_Nb30 |
healthy volunteer |
GSM1156541 | 53 |
M |
PBM_HV_Nb31 |
healthy volunteer |
GSM1156542 | 41 |
F |
PBM_HV_Nb32 |
healthy volunteer |
GSM1156543 | 43 |
F |
PBM_HV_Nb33 |
healthy volunteer |
GSM1156544 | 45 |
F |
PBM_HV_Nb34 |
healthy volunteer |
GSM1156545 | 49 |
F |
PBM_HV_Nb35 |
healthy volunteer |
GSM1156546 | 44 |
F |
PBM_HV_Nb36 |
healthy volunteer |
GSM1156547 | 59 |
F |
PBM_HV_Nb37 |
healthy volunteer |
GSM1156548 | 50 |
F |
PBM_HV_Nb38 |
healthy volunteer |
GSM1156549 | 63 |
F |
PBM_PM_Nb62 |
metastatic patient |
GSM1156550 | 66 |
M |
PBM_HV_Nb4 |
healthy volunteer |
GSM1156551 | 64 |
F |
PBM_HV_Nb2 |
healthy volunteer |
GSM1156552 | 77 |
F |
PBM_HV_Nb6 |
healthy volunteer |
GSM1156553 | 52 |
F |
PBM_HV_Nb19 |
healthy volunteer |
GSM1156554 | 45 |
M |
PBM_HV_Nb20 |
healthy volunteer |
GSM1156555 | 48 |
F |
PBM_HV_Nb21 |
healthy volunteer |
GSM1156556 | 55 |
M |
PBM_HV_Nb22 |
healthy volunteer |
GSM1156557 | 47 |
M |
PBM_HV_Nb23 |
healthy volunteer |
GSM1156558 | 45 |
F |
PBM_HV_Nb24 |
healthy volunteer |
GSM1156559 | 48 |
F |
PBM_HV_Nb25 |
healthy volunteer |
GSM1156560 | 43 |
F |
PBM_HV_Nb26 |
healthy volunteer |
GSM1156561 | 72 |
F |
PBM_PM_Nb43 |
metastatic patient |
GSM1156562 | 64 |
F |
PBM_HV_Nb1 |
healthy volunteer |
GSM1156563 | 58 |
M |
PBM_HV_Nb3 |
healthy volunteer |
GSM1156564 | 70 |
F |
PBM_HV_Nb5 |
healthy volunteer |
GSM1156565 | 74 |
F |
PBM_HV_Nb7 |
healthy volunteer |
GSM1156566 | 77 |
M |
PBM_HV_Nb8 |
healthy volunteer |
GSM1156567 | 46 |
F |
PBM_HV_Nb9 |
healthy volunteer |
GSM1156568 | 79 |
M |
PBM_HV_Nb10 |
healthy volunteer |
GSM1156569 | 78 |
M |
PBM_HV_Nb11 |
healthy volunteer |
GSM1156570 | 63 |
F |
PBM_HV_Nb13 |
healthy volunteer |
GSM1156571 | 65 |
F |
PBM_HV_Nb14 |
healthy volunteer |
GSM1156572 | 42 |
F |
PBM_HV_Nb15 |
healthy volunteer |
GSM1156573 | 72 |
F |
PBM_HV_Nb16 |
healthy volunteer |
GSM1156574 | 64 |
F |
PBM_HV_Nb17 |
healthy volunteer |
GSM1156575 | --- |
--- |
PBM_PM_Nb63 |
metastatic patient |
GSM1156576 | --- |
--- |
PBM_PM_Nb64 |
metastatic patient |
GSM1156577 | --- |
--- |
PBM_HV_Nb39 |
healthy volunteer |
GSM1156578 | --- |
--- |
PBM_HV_Nb40 |
healthy volunteer |
GSM1156579 | 65 |
F |
PBM_P_Nb9 |
non-metastatic patient |
GSM1156580 | 71 |
F |
PBM_PM_Nb37 |
metastatic patient |
GSM1156581 | 74 |
M |
PBM_P_Nb48 |
non-metastatic patient |
GSM1156582 | 76 |
F |
PBM_PM_Nb1 |
metastatic patient |
GSM1156583 | 75 |
F |
PBM_PM_Nb3 |
metastatic patient |
GSM1156584 | 78 |
M |
PBM_P_Nb4 |
non-metastatic patient |
GSM1156585 | 65 |
F |
PBM_P_Nb5 |
non-metastatic patient |
GSM1156586 | 67 |
M |
PBM_P_Nb6 |
non-metastatic patient |
GSM1156587 | 66 |
F |
PBM_PM_Nb11 |
metastatic patient |
GSM1156588 | 49 |
F |
PBM_P_Nb12 |
non-metastatic patient |
GSM1156589 | 69 |
F |
PBM_PM_Nb13 |
metastatic patient |
GSM1156590 | 73 |
M |
PBM_P_Nb14 |
non-metastatic patient |
GSM1156591 | 64 |
F |
PBM_PM_Nb15 |
metastatic patient |
GSM1156592 | 46 |
F |
PBM_PM_Nb16 |
metastatic patient |
GSM1156593 | 78 |
M |
PBM_PM_Nb17 |
metastatic patient |
GSM1156594 | 77 |
M |
PBM_P_Nb18 |
non-metastatic patient |
GSM1156595 | 67 |
M |
PBM_P_Nb20 |
non-metastatic patient |
GSM1156596 | 79 |
M |
PBM_P_Nb21 |
non-metastatic patient |
GSM1156597 | 68 |
F |
PBM_P_Nb22 |
non-metastatic patient |
GSM1156598 | --- |
--- |
PBM_PM_Nb23 |
metastatic patient |
GSM1156599 | 71 |
F |
PBM_P_Nb24 |
non-metastatic patient |
GSM1156600 | 65 |
F |
PBM_PM_Nb25 |
metastatic patient |
GSM1156601 | 62 |
F |
PBM_PM_Nb27 |
metastatic patient |
GSM1156602 | 65 |
F |
PBM_PM_Nb28 |
metastatic patient |
GSM1156603 | 65 |
F |
PBM_P_Nb31 |
non-metastatic patient |
GSM1156604 | 81 |
M |
PBM_P_Nb39 |
non-metastatic patient |
GSM1156605 | 45 |
F |
PBM_P_Nb40 |
non-metastatic patient |
Name | ||
---|---|---|
All Samples | View | |
Tumor stage | Default | View |
In order to make new Group Sets or change settings, please log in. |
Group Set | |
---|---|
All Samples | |
Tumor stage |